Cegedim Santé Acquires Médoucine, the “Doctolib of Alternative Medicine”

Why It Matters

The purchase expands Cegedim’s digital health portfolio into the fast‑growing complementary‑medicine sector, creating new cross‑referral pathways and revenue opportunities, while signaling broader acceptance of alternative health services in France.

Key Takeaways

• Cegedim Santé adds Médoucine, tapping France’s 80k alternative practitioners.
• Médoucine posted €2 million (≈$2.2 million) annual revenue, profitable alone.
• Platform remains independent; CEO Solange Arnaud stays in charge.
• Subscription model offers scheduling, visibility, and peer reviews for practitioners.
• Acquisition aims to link conventional doctors with complementary care providers.

Pulse Analysis

Cegedim Santé, best known for its Maiia appointment‑booking system for RPPS‑registered clinicians, is diversifying its health‑tech portfolio by acquiring Médoucine. The French market for complementary‑medicine services—encompassing naturopathy, sophrology, hypnotherapy and more—hosts roughly 80,000 practitioners, a segment traditionally outside the scope of conventional digital health platforms. By adding Médoucine’s specialist network, Cegedim not only broadens its addressable user base but also positions itself to capture a slice of the estimated €3‑4 billion European alternative‑care market that is increasingly digitized.

Médoucine operates on a subscription model that mirrors Doctolib’s core offering: practitioners pay for visibility, scheduling tools, and access to a peer community, while patients benefit from vetted profiles and post‑consultation reviews. The platform’s profitability—€2 million in revenue, roughly $2.2 million, on a standalone basis—demonstrates that niche health‑tech solutions can achieve sustainable margins without large‑scale integration. Recent clearance by France’s consumer‑protection authority, after a thorough DGCCRF audit, further validates its compliance framework, easing concerns about practitioner legitimacy that have plagued the sector.

Strategically, the acquisition enables Cegedim to create referral pathways between conventional physicians using Maiia and alternative‑care providers on Médoucine. Such bridges could foster integrated care plans, improve patient outcomes, and unlock new monetization models, such as joint subscription bundles or data‑driven health insights. Industry observers view this move as a bellwether for mainstream health‑tech firms embracing holistic wellness ecosystems, a trend likely to accelerate as patients seek coordinated, multi‑modal treatment options. The upcoming Assises des Pratiques Complémentaires in November will likely reveal concrete partnership pilots and roadmap milestones.